What's New
News
AFTD CEO Discusses Wendy Williams’s FTD Diagnosis
In an interview with The Daily Beast about Wendy Williams’s recent FTD diagnosis, AFTD CEO Susan L-J…
FDA Grants Breakthrough Therapy Designation to Experimental FTD Therapy
The U.S. Food and Drug Administration (FDA) has granted a “breakthrough therapy designation” to latozinemab, an experimental…
AFTD and ADDF Extend Treat FTD Fund Program Through 2035
AFTD and the Alzheimer’s Drug Discovery Foundation (ADDF) have committed to extending the Treat FTD Fund program…
Open Hand Foundation Provides AFTD $600K for FTD Research
AFTD is pleased to announce that we have received a gift of $600,000 from the Open Hand…
Provide Help and Bring Hope with a Year-End Gift
AFTD was founded more than 20 years ago with a single donation. Since then, the dedication and…
U.S. Rep. Jennifer Wexton Announces Progressive Supranuclear Palsy Diagnosis
Representative Jennifer Wexton of Virginia announced last week that she would not be seeking re-election after receiving…
